Alexion Pharmaceuticals, Inc.
TREATING SEIZURE WITH RECOMBINANT ALKALINE PHOSPHATASE
Last updated:
Abstract:
The present disclosure provides a method of treating seizure in a subject having aberrant alkaline phosphatase activities, comprising administering a therapeutically effective amount of at least one recombinant alkaline phosphatase to the subject.
Status:
Application
Type:
Utility
Filling date:
18 Oct 2019
Issue date:
26 Mar 2020